We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01044069
Recruitment Status : Active, not recruiting
First Posted : January 7, 2010
Last Update Posted : May 16, 2017
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center